Medigen Vaccine Biologics (高端疫苗生物製劑股份有限公司) is a company developing vaccines and biosimilars to prevent regional infectious diseases. It provides vaccines against enterovirus, pandemic influenza, and dengue virus. The company also offers the Palivizumab biosimilar to prevent respiratory syncytial virus (RSV).